News

The initiative will utilize PDI’s exclusive Select Access Team to reach pediatricians. The fee-for-service contract, commencing January 2008, is expected to generate approximately $7.5 million in revenue for

The Tryton Side-Branch Stent is a high performance cobalt chromium balloon-expandable coronary stent. Richard Davis, chief technology officer of Tryton, said: “CE Mark will allow us to bring

This acquisition is expected to significantly accelerate AMRI’s ability to make custom pilot scale intermediates in India, which is expected to commence in the Q2 of 2008. AMRI

The primary endpoint of the study was the sum of pain intensity differences between baseline and day 21. Nalbuphine ER (nalbuphine hydrochloride extended release) did not meet this

Orphan drug designation entitles VioQuest to seven years of marketing exclusivity for VQD-002 upon regulatory approval, as well as the opportunity to apply for grant funding from the

Under the terms of the agreement GlaxoSmithKline (GSK) will be granted an exclusive, worldwide license to develop, manufacture and commercialize Amira’s FLAP inhibitors, including AM103 and other compounds

Asmanex (mometasone furoate inhalation powder) is an inhaled corticosteroid (ICS). Continual use of Asmanex helps manage asthma symptoms in patients with persistent asthma. Additionally, its automatic dose counter

Psorent contains LCD (liquid carbonis distillate), which has shown efficacy against psoriasis symptoms in a novel, aesthetically advanced formulation and package that promotes high patient compliance. Psorent will

Hans Petersen, president and CEO of Traversa, said: “The technology has received an outstanding level of interest for use with human therapeutics, and as a high throughput screening